Abiopharma

OPKO Health Expands Nicoya Agreement to SupportRAYALDEE® Commercialization in Greater China

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

Newton Golf Sets First Quarter 2026 Conference Call for Thursday, May 14, 2026 at 4:30 p.m. ET

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Teva Pharmaceutical Industries Ltd. - Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets

Global Water Resources Declares Monthly Dividend

ESS Partners with Alsym Energy to Deliver 8.5 GWh of Non-Lithium Battery Energy Storage Solutions

LightPath Technologies to Host Third Quarter Fiscal 2026 Earnings Call on May 7 at 5:00 p.m. Eastern Time

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)